5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2
作者:Michael P. Dickens、Patricia Roxburgh、Andreas Hock、Mokdad Mezna、Barrie Kellam、Karen H. Vousden、Peter M. Fischer
DOI:10.1016/j.bmc.2013.09.038
日期:2013.11
Based on previous reports of certain 5-deazaflavin derivatives being capable of activating the tumour suppressor p53 in cancer cells through inhibition of the p53-specific ubiquitin E3 ligase HDM2, we have conducted an structure-activity relationship (SAR) analysis through systematic modification of the 5-deazaflavin template. This analysis shows that HDM2-inhibitory activity depends on a combination of factors. The most active compounds (e. g., 15) contain a trifluoromethyl or chloro substituent at the deazaflavin C9 position and this activity depends to a large extent on the presence of at least one additional halogen or methyl substituent of the phenyl group at N10. Our SAR results, in combination with the HDM2 RING domain receptor recognition model we present, form the basis for the design of drug-like and potent activators of p53 for potential cancer therapy. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
A straightforward synthesis of pyrimido[4,5-b]quinoline derivatives assisted by microwave irradiation
Several pyrimido[4,5-b]quinolines, flavin analogues, have been prepared by assisted microwave intramolecular cyclization of N4-substituted-2,4-diamino-6-chloropyrimidine-5-carbaldehydes. The reaction takes place with hydrolysis of amino-group and chlorine. Particularly valuable features of this method included the broader substrate scope and operational simplicity as well as increased safety for small-scale
通过N 4取代的2,4-二氨基-6-氯嘧啶-5-甲醛的微波辅助分子内环化反应,已经制备了几种嘧啶[4,5- b ]喹啉,黄素类似物。该反应在氨基和氯的水解下进行。该方法特别有价值的特征包括更宽的基板范围和操作简便性,以及用于小规模高速合成的更高的安全性。